CPT code 87632: Respiratory panel, six to eleven targets2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Reports multiplex nucleic acid testing for 6–11 respiratory virus targets when a clinician evaluates a patient for viral respiratory infection.
Medicare pays $218.06 for 87632 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$218.06
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 87632 covers
This molecular laboratory test uses nucleic acid detection to identify multiple respiratory-virus types or subtypes in a multiplex assay. The panel has six to eleven targets; target organisms can include adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, or rhinovirus. It is used when testing is directed at several possible viral causes of respiratory illness, rather than a single-virus assay. Clinical laboratories perform and report the test.
Report 87632 according to the number of targets in the multiplex panel, not once per target detected. Medicare pays the test through the CLFS only. Its 2026 national amount is $218.06 and has remained unchanged since 2020. The CLFS amount is the same across states and localities, with no geographic adjustment or office-versus-facility difference. The test is excluded from the physician fee schedule and is paid only through the CLFS.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 87632
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 87632. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 87632 with status X (excluded by statute), so the test itself is paid only from the CLFS.
87632 on the lab fee schedule since 2020
87632 · CLFS 2026 Q4 (current)
$218.06
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
87632 compared with similar tests
- 87631Respiratory virus panelThree to five targets$142.63
- 87631 applies to a respiratory virus multiplex panel with 3–5 targets; 87632 applies when the panel has 6–11.
- 87633Respiratory panel12–25 targets$416.78
- 87633 is for a larger respiratory virus multiplex panel of 12–25 targets; 87632 covers 6–11.
- 87634RSV testAmplified probe detection$70.20
- 87634 is RSV-specific nucleic acid testing. Use 87632 for a multiplex respiratory virus panel with 6–11 targets.
- 87637Respiratory testSARS-CoV-2, flu, and RSV$142.63
- 87637 is for a fixed multiplex test for SARS-CoV-2, influenza A and B, and RSV; 87632 is selected by its 6–11-target panel size.
87632 billing questions
How does 87632 differ from 87631 and 87633?
Select among these codes by the number of respiratory virus targets in the multiplex test: 87631 covers 3–5, 87632 covers 6–11, and 87633 covers 12–25.
Is the code reported once for each virus detected?
No. Report the multiplex test based on its panel target count, not separately for each positive target.
When would a laboratory use 87632 rather than an RSV-specific test?
Use 87632 for a multiplex respiratory virus test with 6–11 targets. Code 87634 describes RSV nucleic acid testing rather than the broader target-count panel.
Does Medicare pay 87632 under the physician fee schedule?
No. Medicare pays the test only through the CLFS, at one national amount that applies in every locality.
What should the laboratory documentation support?
Documentation should identify the multiplex respiratory virus test performed and support that its panel falls within the six-to-eleven-target range.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 87632 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist